Xenon Pharmaceuticals Inc (NAS:XENE)
$ 43.33 1.62 (3.88%) Market Cap: 3.28 Bil Enterprise Value: 2.45 Bil PE Ratio: 0 PB Ratio: 3.88 GF Score: 41/100

Xenon Pharmaceuticals Inc Discussion of XEN1101 and the Focal Epilepsy Landscape Transcript

Jul 12, 2021 / 02:00PM GMT
Release Date Price: $18.41 (-1.07%)
Jodi Regts
Xenon Pharmaceuticals Inc. - VP of Corporate Affairs & IR

Welcome to the Xenon Pharmaceuticals Investor Webinar. This call is being webcast live on the Investors section of Xenon's website at xenon-pharma.com. This broadcast is property of Xenon Pharmaceuticals and recording, reproduction or transmission of this call without the express written consent of Xenon is strictly prohibited. Please note this call is being recorded.

I would now like to introduce Ian Mortimer, President and CEO at Xenon Pharmaceuticals, who will act as a moderator of today's event. Ian?

Ian C. Mortimer
Xenon Pharmaceuticals Inc. - President, CEO & Director

Thanks, Jodi, and good morning, everyone. Thanks for joining us today on our webinar. Before we begin, I'll point out that we will be making some forward-looking statements, which are based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties, and our actual results may differ materially. Please consult the risk factors discussed in the press release

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot